Literature DB >> 7691634

Comparative effects of suppressive cytokines on isolated single CD34(3+) stem/progenitor cells from human bone marrow and umbilical cord blood plated with and without serum.

L Lu1, M Xiao, S Grigsby, W X Wang, B Wu, R N Shen, H E Broxmeyer.   

Abstract

A number of cytokines have been implicated in the suppression of myeloid stem and progenitor cell proliferation. It has been suggested that some of these act directly on the stem/progenitors themselves, based on the effects of these cells, plated in culture at low seeding densities, on highly enriched populations. These studies, however, do not definitively rule out effects on accessory cells. To more rigorously evaluate direct-acting suppressive effects of cytokines, such cytokines were assessed for their effects on colony formation initiated by single bone marrow (BM) or umbilical cord blood (CB) CD34 cells sorted into single wells in the presence of a combination of growth-stimulating cytokines (erythropoietin [Epo], steel factor [SLF], granulocyte-macrophage colony-stimulating factor [GM-CSF], and interleukin-3 [IL-3]) and in the presence or absence of serum. Under these conditions, it was demonstrated that H-ferritin, transforming growth factor-beta 1 (TGF-beta 1), and members of the chemokine family (macrophage inflammatory protein-1 alpha [MIP-1 alpha], MIP-2 beta, platelet factor 4 [PF4], IL-8, and macrophage chemotactic and activating factor [MCAF]) had direct significant suppressive activities on single stem/progenitor cells from adult human BM in the presence or absence of serum. Single sorted CB cells were much less sensitive to inhibition by these cytokines. The reasons for this differential sensitivity are not known. Of possible relevance to this for cytokines, such as H-ferritin and the chemokines that have actions during S-phase of the cell cycle, CB progenitors were in slower cycle at initiation of culture than were BM progenitors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691634

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  15 in total

Review 1.  Regulation of hematopoiesis by chemokine family members.

Authors:  H E Broxmeyer
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

2.  Early and persistent bone marrow hematopoiesis defect in simian/human immunodeficiency virus-infected macaques despite efficient reduction of viremia by highly active antiretroviral therapy during primary infection.

Authors:  H Thiebot; F Louache; B Vaslin; T de Revel; O Neildez; J Larghero; W Vainchenker; D Dormont; R Le Grand
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Neurexophilin 1 suppresses the proliferation of hematopoietic progenitor cells.

Authors:  John Kinzfogl; Giao Hangoc; Hal E Broxmeyer
Journal:  Blood       Date:  2011-05-31       Impact factor: 22.113

Review 4.  Transforming growth factor beta, pleiotropic regulator of hematopoietic stem cells: potential physiological and clinical relevance.

Authors:  F W Ruscetti; S H Bartelmez
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

5.  Hyaluronan expressed by the hematopoietic microenvironment is required for bone marrow hematopoiesis.

Authors:  Valentina Goncharova; Naira Serobyan; Shinji Iizuka; Ingrid Schraufstatter; Audrey de Ridder; Tatiana Povaliy; Valentina Wacker; Naoki Itano; Koji Kimata; Irina A Orlovskaja; Yu Yamaguchi; Sophia Khaldoyanidi
Journal:  J Biol Chem       Date:  2012-05-31       Impact factor: 5.157

6.  Modulation of Hematopoietic Chemokine Effects In Vitro and In Vivo by DPP-4/CD26.

Authors:  Hal E Broxmeyer; Maegan Capitano; Timothy B Campbell; Giao Hangoc; Scott Cooper
Journal:  Stem Cells Dev       Date:  2016-03-30       Impact factor: 3.272

7.  Genetic modification of human hematopoietic cells: preclinical optimization of oncoretroviral-mediated gene transfer for clinical trials.

Authors:  Tulin Budak-Alpdogan; Isabelle Rivière
Journal:  Methods Mol Biol       Date:  2009

8.  Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice.

Authors:  H E Broxmeyer; S Cooper; N Hague; L Benninger; A Sarris; K Cornetta; S Vadhan-Raj; P Hendrie; C Mantel
Journal:  Ann Hematol       Date:  1995-11       Impact factor: 3.673

9.  CXCL15/Lungkine has suppressive activity on proliferation and expansion of multi-potential, erythroid, granulocyte and macrophage progenitors in S-phase specific manner.

Authors:  Hal E Broxmeyer; Scott H Cooper; James Ropa
Journal:  Blood Cells Mol Dis       Date:  2021-07-03       Impact factor: 2.372

10.  Involvement of Interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue.

Authors:  H E Broxmeyer; S Cooper; G Cacalano; N L Hague; E Bailish; M W Moore
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.